Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2... | RTCL.TV
### Keywords ###
#inflammatorydiseases #therapeuticdrug #treatinflammatory #signal #called #Tozorakimab #signalactivates #RTCLTV #shorts
### Article Attribution ###
Title: Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Authors: Elizabeth England, D. Gareth Rees, Ian Christopher Scott, Sara Carmen, Denice T. Y. Chan, Catherine E. Chaillan Huntington, Kirsty F. Houslay, Teodor Erngren, Mark Penney, Jayesh B. Majithiya, Laura Rapley, Dorothy A. Sims, Claire Hollins, Elizabeth C. Hinchy, Martin D. Strain, Benjamin P. Kemp, Dominic J. Corkill, Richard D. May, Katherine A. Vousden, Robin J. Butler, Tomas Mustelin, Tristan J. Vaughan, David C. Lowe, Caroline Colley ,and E. Suzanne Cohen
Publisher: Nature Portfolio
DOI: 10.1038/s41598-023-36642-y
DOAJ URL:
https://doaj.org/article/4d1e1f2da3f148aa85e1df6a32f0ef69Source URL:
https://doi.org/10.1038/s41598-023-36642-y### Image Attribution ###
We used stable diffusion to programmatically generate the background images.
Viewer discretion is advised.
### Channels ###
YouTube Channel:
https://www.youtube.com/@medicinertcltvOdysee Channel:
https://odysee.com/@medicine_rtcl_tv### Video Timestamps ###
0:00:00 - Summary
0:00:47 - Title
0:00:53 - End